Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06894433 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of NeuroEndoscopic Surgery for Large IntraCerebral Hemorrhage

Study acronym: NESICH 2
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Mar 20, 2025 to Jun 1, 2025
    • Secondary endpoints revised (11)
    • Study description expanded, about 1 word
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multicenter, randomized, controlled clinical trial comparing neuroendoscopic hematoma removal to craniotomy in the treatment of large intracerebral hemorrhage.
Trial Details
NCT Number NCT06894433
Lead Sponsor Southwest Hospital, China
Conditions
(from sponsor)		 Intracerebral Haemorrhage
Related terms Cerebral Hemorrhage
Enrollment 280 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov